Biotech Stock Plunges on Bitcoin Plans as Ethereum Treasuries Stay Hot
Lixte Biotechnology's share price fell hard after it revealed a Bitcoin treasury, while firms stashing Ethereum have been surging of late.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This ethereum story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Ethlabs Calls for Ethereum Quantum Protection in 2027 as Upgrade Priorities Shift
TL;DR: Ethlabs proposes quantum readiness in 2027 and plans to withdraw its quick-slots work from Hegotá. Developers still need to...
Bitcoin Plunges, but Michael Saylor Says STRC Still Delivers Gains
Michael Saylor highlighted positive returns from Strategy’s income-paying preferred shares, traded as STRC, while bitcoin fell nea...
Ethereum Dancing on Two Fronts as Quantum Upgrade Advances and Treasury Leverage Bites
Ethereum developers want to upgrade the network to be quantum-ready by 2027, potentially accelerating one of its biggest security...
Digital Credit: Comparing The Six Bitcoin Preferred Stocks
Bitcoin Magazine Digital Credit: Comparing The Six Bitcoin Preferred Stocks Digital credit is an emerging asset class that transfo...
Kazakhstan plans tokenized government bonds for Q1 2027 after $22M sale
Kazakhstan's move to tokenized bonds could revolutionize financial markets, enhancing transparency and liquidity while attracting...
Ethereum faces temporary issues due to cloud provider malfunction
Cloud dependency highlights Ethereum's vulnerability, urging diversification to ensure network resilience and uninterrupted user a...